Karo Healthcare Website, Blog & Press Pages

Karo Healthcare Website, Blog & Press Pages - aVenture Research

Library

karohealthcare.comCrawled Nov 3, 2026

Press

6 pages

Anders Lönner and Per-Anders Johansson have irrevocably undertaken to accept the public cash offer announced by EQT VIII, through Karo Intressenter AB, on October 29, 2018/anders-lonner-and-per-anders-johansson-have-irrevocably-undertaken-to-accept-the-public-cash-offer-announced-by-eqt-viii-through-karo-intressenter-ab-on-october-29-2018
STOCKHOLM 9 November 2018
Anders Lönner, chairman of the Board Karo Pharma AB, has suddenly passed away/anders-lonner-chairman-of-the-board-karo-pharma-ab-has-suddenly-passed-away
Karo Intressenter’s proposals ahead of the Extraordinary General Meeting in Karo Pharma on 14 February 2019/karo-intressenters-proposals-ahead-of-the-extraordinary-general-meeting-in-karo-pharma-on-14-february-2019
EQT VIII, through Karo Intressenter AB, proposed electing Håkan Åström to the Karo Pharma board and adding Bo Jesper Hansen, Erika Henriksson, Vesa Koskinen, Christoffer Lorenzen, and Åsa Riisberg at the Extraordinary General Meeting on 14 February 2019, with Bo Jesper Hansen as Chairman.
Marketing Territory for Viruseptin Extended to Include Denmark/marketing-territory-for-viruseptin-extended-to-include-denmark
STOCKHOLM 16 November 2018

Homepage

1 page

Homepage/
Karo Healthcare offers a portfolio of everyday healthcare products and services that help prevent illness and treat health problems.

Coverage

6 items

Karo Healthcare appoints Philip Hampden-Smith as Chief Operations Officerkarohealthcare.com/karo-healthcare-appoints-philip-hampden-smith-as-chief-operations-officer/
Karo Healthcare names Philip Hampden-Smith as Chief Operations Officer, adding him to the Corporate Management Team. The appointment expands Karo’s leadership to strengthen operational oversight. No further details on prior experience or specific responsibilities are provided in the announcement.
Aug 2026Karo HealthcareNews article
Karo Group publishes the 2025 Annual Summary and Sustainability Statementkarohealthcare.com/karo-group-publishes-the-2025-annual-summary-and-sustainability-statement/
Karo Group releases its **2025 Annual Summary and Sustainability Statement**, detailing the company’s performance and sustainability efforts for the year. The report is now available on the official Karo Healthcare website. It covers key operational highlights and environmental, social, and governance (ESG) initiatives.
Apr 2026Karo HealthcareNews article
Karo Healthcare appoints Karine Martin as Chief Financial Officerkarohealthcare.com/karo-healthcare-appoints-karine-martin-as-chief-financial-officer/
Karo Healthcare appoints Karine Martin as its new Chief Financial Officer and adds her to the Corporate Management Team. The move expands leadership in financial strategy and operations for the healthcare company.
Mar 2026Karo HealthcareNews article
Karo Healthcare enters an exclusive license agreement with Moberg Pharma for MOB-015 in Europekarohealthcare.com/karo-healthcare-enters-an-exclusive-license-agreement-with-moberg-pharma-for-mob-015-in-europe/
Karo Healthcare secures an exclusive license from Moberg Pharma to commercialize the antifungal compound **MOB-015** across **19 European markets**. The deal leverages the **Lamisil®** brand for a coordinated launch in key regions. The agreement covers development and distribution rights for the compound in Europe.
Nov 2025Karo HealthcareNews article